KCT0003002Active, not recruiting未知
To evaluate detoxification and body fat mass decrease effect and safety of Wellnessup® diet: 4-weeks, Clinical trial
Trial Snapshot
- Phase
- 未知
- Status
- Active, not recruiting
- Enrollment
- 45
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional Study
Eligibility Criteria
- Ages
- 19(Year) to 49(Year) (—)
- Sex
- Female
Inclusion Criteria
- •1) Women over 19 years old and under 49 years old at the time of screening.
- •2) A person with a BMI between 23.5 and 30 kg/m2 at the time of screening.
- •3) The person who has heard and fully understood the full explanation of this human factors testing, and has agreed to voluntarily decide to participate and comply with the cautions.
Exclusion Criteria
- •1) A person who has lost more than 10 percent of weight within three months of screening.
- •2) Who has taken a medication or a health function food product associated with detoxification or weight loss within one month of screening.
- •3) Severe clinical attention is given to acute or chronic cardiovascular system, endocrinology, immune system, respiratory system, cold blood meter, kidney and urinary system, musculoskeletal system, inflammatory disease, and others.
- •4) There are people with gastrointestinal conditions (such as Cronic's disease) who can be affected by the human body's applied test, and people with gastro-related operations (except for simple appendix protrusion subtractomization or hernia).
- •5) Those who overreact about the ingredients in the human diet.
- •6)Who has continuously administered antipsychotics within six months of screening
- •7) A suspected drug abuse or medical history
- •8) Who is constantly drinking alcohol that has exceeded 21 units/week or has a history of alcohol abuse
- •9) Who shows the following in a diagnostic examination medical examination
- •? Serum AST, ALT > three times of the reference range upper limit
- •? Serum creatinine > 2.0 mg/dL
- •10) Who has participated in other human body applications within two months of screening
- •11) Menopause (non-month-free for more than 12 months) or menopause (non-precision for more than three consecutive months) women.
- •12) A woman who is pregnant or is suckling or has plans to be pregnant during the duration of this human body application testing.
- •13) Women who became pregnant with pregnancy agreed not to use effective contraception (condoms, birth control masks, intrauterine contraception, or if a male partner underwent vasectomy) during the trial period.
- •14) A person who has determined that a tester is unsuitable for participating in human factors testing for reasons other than diagnostic testing medical examination results.
Investigators
Similar Trials
Recruiting
Not Applicable
Examination of reduction of hepatic fat mass and hepatic fibrosis inhibitory effect of pemafibrate in type 2 diabetic patients with hyperlipidemia and non-alcoholic fatty liverType 2 diabetesJPRN-UMIN000044389Department of Endocrinology and Metabolism, Dokkyo Medical University60
Completed
Not Applicable
The clinical test to consider the body fat reductional effect by taking functionality egg.Healthy volunteerJPRN-UMIN000016081Anti-Aging Medical Research Center,Graduate School of Life and Medical Sciences,Doshisha Univercity60
Completed
Not Applicable
Effect of reduction in fat mass after laparoscopic obesity on women with ovulatioIRCT201203078588N4Tehran University of Medical Sciences.60
Completed
Not Applicable
Study for confirming body weight, body fat, visceral fat reducing effect by ingesting test food (dose setting test)Healthy adultJPRN-UMIN000033177CPCC Company Limited40
Completed
Not Applicable
Verification of the effectiveness of body fat improvement effect by ingesting healthy foodHealthy adultJPRN-UMIN000043203Japan Clinical Trial Association30